Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice

Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice

Various studies have reported insufficient beta-lactam concentrations in critically ill patients. The extent to which therapeutic drug monitoring (TDM) in clinical practice can reduce insufficient antibiotic concentrations is an ongoing matter of investigation. We retrospectively evaluated routine m...

Full description

Bibliographic Details
Main Authors: Christina Scharf, Michael Paal, Ines Schroeder, Michael Vogeser, Rika Draenert, Michael Irlbeck, Michael Zoller, Uwe Liebchen
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Antibiotics
Subjects:
meropenem
piperacillin
therapeutic drug monitoring (tdm)
critical illness
renal function
pharmacokinetic
experience
Online Access:https://www.mdpi.com/2079-6382/9/3/131

Internet

https://www.mdpi.com/2079-6382/9/3/131

Similar Items